Chuang Yi Biotech

Chuangyi Biotech is a leading Chinese biotechnology company specializing in the research, development, and industrialization of recombinant humanized collagen. Founded in 2021 and headquartered in Guangzhou, the company utilizes a sophisticated synthetic biology platform to produce high-purity collagen proteins that are 100% homologous to human sequences. Their product portfolio includes various types of collagen, such as Type I, III, XVII, and II, which are applied in medical aesthetics, wound healing, hair care, and orthopedics. Chuangyi Biotech has established a full-chain technology platform covering gene design, strain construction, fermentation, and purification, supported by significant venture capital from firms like IDG Capital and Gaorong Capital. The company aims to replace animal-derived collagen with safer, more effective recombinant alternatives for regenerative medicine and consumer health.